Skip to main content
. 2023 Jan 13;11(1):207. doi: 10.3390/biomedicines11010207

Table 1.

Differences between patients treated with hCPAP and conventional oxygen therapy.

Variables hCPAP Conventional Oxygen Younden Index p-Value
Age (years) 69 (61–78) 73 (58–84) <78 0.006
Male Sex n(%) 189/295 (64%) 177/386 (45.9%) 0.01
Hypertension 142/295 (48.1%) 188/384 (48.9%) 0.93
Cardiovascular disease 80/295 (27.1%) 117/384 (30%) 0.14
Respiratory diseases 44/295 (14.9%) 60/384 (15.6%) 0.10
Chronic kidney disease 35/295 (11.8%) 68/386 (17.6%) 0.04
Active cancer 26/295 (8.8%) 28/386 (7.3%) 0.047
Severe obesity 42/295 (14.2%) 34/384 (8.9%) 0.004
Neuropsychiatric disorders 34/295 (11.5%) 99/386 (25.6%) <0.001
Diabetes 50/295 (16.9%) 81/384 (21%) 0.08
Polytherapy at home 137/295 (46.4%) 183/384 (47.7%) 0.62
Haemoglobin (g/dL) 14 (13–15) 13 (12–15) >13 <0.001
Platelets (109/L) 207 (157–260) 204 (163–259) 0.98
Neutrophils (units/L) 5900 (4550–8600) 4900 (3370–7650) >4700 <0.001
Lymphocytes (units/L) 800 (570–1100) 860 (600–1200) 0.30
International Normalized Ratio (INR) 1.2 (1.1–1.3) 1.1 (1.0–1.2) >1.1 0.026
D-dimer (µg/mL) 847 (523–1550) 900 (530–1500) 0.95
Fibrinogen (mg/dL) 770 (640–880) 680 (570–790) <0.001
Aspartate aminotransferase (U/L) 39 (31–54) 31 (24–46) >33 <0.001
Alanine aminotransferase (U/L) 31 (19–51) 24 (16–39) <0.001
Lactate dehydrogenase (U/L) 620 (480–760) 470 (380–600) >570 <0.001
Total Bilirubin (mg/dL) 0.6 (0.5–0.8) 0.6 (0.5–0.8) 0.125
C-reactive protein (mg/dL) 8.3 (4–13) 4.8 (2–11) >4.6 <0.001
Procalcitonin (ng/mL) 0.12 (0.07–0.3) 0.09 (0.05–0.22) >0.1 <0.001
Interleukin-6 (pg/mL) 58 (31–100) 34 (14–66) >46 <0.001
Horowitz Index 230 (130–275) 260 (180–310) <270 0.006
Brain natriuretic peptide (pg/mL) 64 (35–140) 79 (34–190) 0.31
Call score 12 (10–13) 11 (9–12) >9 <0.001